Complement is a central defence against sepsis, and increasing complement insufficiency in neonates of greater prematurity may predispose to increased sepsis.
| INTRODUCTION
The complement system encompasses a series of >30 serum proteins that interact through an amplification cascade following activation by foreign microbial surfaces, immune complexes, surface-bound antibodies or pathogen-bound pattern recognition molecules. Like most elements of the innate immune system, the complement system does not require previous exposure to be effective. Complement also acts to integrate the innate and humoral immune responses through recruiting innate and adaptive immune cells to the site of activation (via chemotaxin and anaphylotoxin release), improving the humoral response through a natural adjuvant activity and increasing engulfment of microbes through decorating the surface with opsonins.
1
Complement has direct antimicrobial activity mediated by the formation of lytic pores on activating surfaces, which makes it a pivotal barrier to initial invasion by pathogens. However, as we have previously reviewed, the complement system does not have full potency (for both activation and regulatory factors) at birth in humans due to lower circulating levels of some of the components, and this insufficiency is greater with increasing prematurity. 2 The reduced capacity of the complement system at term and birth, which is exacerbated with increasing prematurity, has been proposed to be responsible for the increased susceptibility of neonates to bacterial infection and sepsis. 3 Intrauterine infection by Ureaplasma parvum (UP) is strongly associated with preterm birth and is among the organisms most commonly isolated from gestational tissues. 4, 5 UP is one of the smallest selfreplicating microorganisms identified to date with a minimal genome (0.75-0.78 Mbp) that limits it to a parasitic existence. 6 Most notably, the UP genome does not encode any components that make up a cell wall, which is common to most bacteria and therefore inherently resistant to all classes of antibiotics that function by inhibiting cell wall synthesis. The cell wall also confers a protective effect against membrane attack complex-mediated complement killing (particularly effective for
Gram-positive bacteria), which may explain why UP is relatively susceptible to human complement.
7
Ureaplasma bacteraemia is detected in up to 23% of preterm cord blood samples 4 and was isolated from blood samples in a cohort of 200 preterm neonates, 8 showing that this organism represents one of the most prevalent systemic infections in births under 32-week gestational age. To determine whether sheep could be used as an in vivo model to investigate the correlation of complement development and bacteraemia with increasing prematurity observed in humans,
we have examined bacteraemia and complement function using a well-established experimental model for in utero UP infection.
9-11
Here, we investigate the ability of adult and preterm sheep sera to kill U. parvum in vitro and investigate the presence of foetal U. parvum bacteraemia following experimental intrauterine infection in vivo.
We hypothesized that, in a sheep model of pregnancy, the degree of gestation-dependent complement insufficiency in preterm lambs would correlate with foetal UP bacteraemia. To investigate this hypothesis, we examined the following: (i) plasma titres of UP from lambs delivered at early-term (95 days) and mid-term (125 days) gestations,
(ii) foetal anti-UP antibody responses, (iii) UP killing activity of serum from adult sheep and preterm lambs, and (iv) the kinetics and calcium dependence of serum UP killing activity. Maternal blood samples for comparative complement function assays were collected from pregnant, UP-naïve ewes into serum separator tubes as above.
| METHODS

| Animal studies
| Ureaplasma parvum culture and killing assay
The serovar 3 strain HPA5 of Ureaplasma parvum (UP) 13 
| Haemolysis assay
Haemolysis assays were performed as previously published. 15 Guinea pig erythrocytes were purchased from TCS Biosciences (Oxford, UK) and sensitized with rabbit polyclonal anti-guinea pig erythrocyte antibodies purchased from Fitzgerald Industries International (North Acton, MA), as described previously. 15 Sheep serum from pregnant ewes and their singleton lambs were obtained by peripheral venepuncture of Merino cross ewes, and foetal cord blood was obtained from their lambs during surgical delivery at 95-and 125-d GA. Sera from both uninfected control and UP-infected sheep were examined. Sera were stored at −80°C prior to use, and aliquots only thawed once.
| IgG quantitation and anti-UP response
IgG concentrations in all sera were determined by commercial Sheep IgG ELISA (Life Diagnostics Inc., West Chester, PA, USA) as per manufacturer's instructions. Results were performed in duplicate, and assays were repeated once. IgG is not transferred across the ovine placenta, 16, 17 resulting in hypogammaglobulinaemia in pre-suckle lambs; 18 therefore, in utero IgG levels can only have arisen by production by the foetus. The reactivity of foetal antibodies for UP in the foetal sera was determined by immunoblot analysis as previously described for human studies. ImmunoResearch, UK).
| Statistical analyses
All values represent mean ± standard deviation (SD). Statistical analy- 
| RESULTS
| Ureaplasma-cidal activity of serum from adult sheep and preterm lambs
The capacity for sera collected from UP-naïve adult and preterm 
| Plasma titres of UP from UP-infected lambs of different gestational ages
In agreement with the in vitro bactericidal assays, the ability to cul- Amniotic fluid UP titres were independent of the length of infection or gestational age (range=5x10 6 − 3x10 7 infectious units/mL; data not shown). However, the identification of foetal UP bacteraemia varied greatly between groups. None of the Group 4 animals had detectable UP bacteraemia; serum UP was detected in only one Group 5 foetus (500 infectious units/mL). In contrast, 50% of Group 2 lambs (delivered at 95-d GA) had UP bacteraemia ranging from 500 to 500 000 infectious units/mL (Table 1 ; Figure 2 ). None of the uninfected control animals (groups 1 and 3) had UP in either AF or foetal serum. shown. Significant differences were found between all points by twofactor ANOVA (dilution and age of serum source/addition of EGTA), and Bonferroni post hoc analysis found significant reduction relative to adult serum killing for all data points after five-minute incubation. Significant differences were found by two-factor ANOVA (dilution and age of donor), and Bonferroni post hoc analysis found significant reduction relative to adult serum killing for all points but 125-d GA sera at 50% dilution. P<.01=**; P<.001=*** 
| Immunoblot analysis of antibody response in preterm lambs
Measurement of total serum IgG showed minimal antibody levels in all groups, apart from Group 4, which were exposed to intraamniotic UP for 42 days prior to delivery at 125-d GA ( Figure 3A ).
Immunoblot analysis was performed on all sera, but only those with elevated IgG levels in Group 4 were found to have anti-UP antibody response against the parental infecting strain (HPA5). Development of antibodies reacting to conserved antigens expressed by other noninfected strains was also evaluated by reactivity to an unrelated UP serovar 6 strain by immunoblot ( Figure 3B ). Despite elevated IgG levels in one of the Group 2 and one Group 5 animal, these sera did not react with UP by immunoblot ( Figure 3B 
| Ureaplasma-cidal activity of sera from bacteraemic vs non-bacteraemic lambs
As no relative serum resistance was observed for isolates recovered from plasma compared to amniotic fluid, the capacity of the sera from bacteraemic and non-bacteraemic 95-d GA preterm lambs was compared for their individual capacity to kill the parental strain inoculated into the pregnant sheep. Endogenous UP in bacteraemic sera was removed by filtration through a 0.22-μm filter, and removal of endogenous UP was confirmed by titration of filtered sera in Ureaplasma-selective medium. The serum killing from the 95-d GA UP-infected animals in Group 2 was higher for nonbacteraemic than for bacteraemic with one exception ( Figure 5 ; lamb 116), which was also the lamb with the lowest detectable UP bacteraemia levels ( Figure 2 ). Further, it was noted that the serum with the lowest UP killing activity was from the animal with the highest plasma titre of UP (lamb 115). These data suggested that killing capacity of the sera was directly linked to UP titres in the serum. 
| DISCUSSION
Neonates, particularly those born preterm (<37-weeks gestation), are frequently immunologically compromised and are more susceptible to morbidity and mortality due to infections. 19 Previously, we developed a haemolysis assay to examine the complement function in sheep, as sheep erythrocytes are the common target for complement function in other species, 15 and here, we have extended the use of our experimental intrauterine UP infection model to examine the role of complement insufficiency as a determining factor for development of in utero sepsis. Sepsis is a life-threatening response to infection leading to tissue and organ damage, often identified through the accompanying fever, tachycardia, tachypnea and febrile morbidity. Due to the collection of samples in our experimental infection model at Caesarean section delivery under euthanasia conditions, measurement of temperature, breathing and heart rate could not be obtained in a meaningful manner. Therefore, while we have examined bacteraemia as a surrogate marker of sepsis, it is important to note that sepsis (the body's response to infection) in patients can occur in the absence of bacteraemia and still responds to antibiotic treatment. GA sera (groups 1 and 3; Figure 3 ), 1.6 ± 0.2 μg/mL and 2. 1 ± 0.5 μg/ mL respectively, confirmed no transplacental maternal IgG transfer (maternal IgG levels were 14,400 ± 889 μg/mL) which has been speculated to be due to placental structure 16, 17 
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The HPA5 strain is susceptible to human serum killing in the absence of specific anti-UP antibodies.
14 As with human serum studies with this strain, sheep serum bactericidal activity required the presence of calcium. However, we are unable to determine whether the bactericidal activity in sheep is mediated by the classical or lectin pathways (both require calcium), as we lack the reagents to differentially block these pathways as were performed for human sera. 
